Date of release May 2026 (WG1,WG2,WG3)

Deliverable description.

The deliverable reports the activities carried out to support the identification and prioritization of new antiparasitic drug candidates for vector-borne parasitic diseases, addressing the limitations of current therapies and the need to reduce environmental toxicity from the earliest stages of drug discovery. Within this framework, biological targets and compound collections made available by CA21111 members were collected, organized and integrated into two complementary resources: the BioTarget Database and the Virtual Chemotheca. These resources provided the basis for a coordinated structure-based screening workflow in which target and compound information were cross-referenced through a docking campaign conducted within the OHD:LUB project.
The OHD1 Target Database project established the BioTarget Database (BioT-DB), a structured resource for collecting and sharing information on biological targets investigated by CA21111 members. The database is organized into ten coordinated sections. Each target record combines general identifiers and sequence information, including links to UniProtKB and BRENDA, with functional annotation, production protocols, biochemical and biophysical characterisation, omics evidence, medium- and high-throughput screening data, and selectivity or specificity profiles. A dedicated structural section records available and unpublished information derived from X-ray crystallography, cryo-EM, BioSAXS and NMR, with links to PDB, EMDB, SASBDB and BMRB. Ecotoxicological relevance is documented through SeqAPASS or related approaches.

The resource was designed to facilitate internal collaboration by associating experimental information with contributor contact details and by enabling future integration with the CA21111 compound databases. As summarised in Table 1, the current dataset comprises 15 target entries from Leishmania and Trypanosoma species, covering redox enzymes, polyamine metabolism, sirtuins, folate and pteridine pathways, phosphohydrolase activity and a chaperone protein. Following scientific curation and validation, the information associated with these targets will be published in the BioTarget Database FAIRDOM-HUB, supporting FAIR access, traceability, reuse and continued community updating. 

Then, the OHD:LUB Project connected compound collections (Virtual Chemotheca), target structures and environmental prioritisation. Compound libraries were docked against the official panel of 20 antiparasitic targets, and the resulting poses were processed through a decision layer combining docking information, predicted ADME/Tox properties and ecotoxicological scores. The computational workflow generated 32,143 docked compound states. This value represents protonation, tautomeric or docking states and must not be interpreted as the number of unique compounds in the Chemotheca.

 

Deliverable 7 - Report on HTS assays and structural biology. (M42)

COST
What is COST?

COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. The COST ACTIONS help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.

OneHealthdrugs CA21111
Title:

One Health drugs against parasitic vector borne diseases in Europe and beyond

Acronym:

OneHealthdrugs

Start date of the Action:

24/10/2022

End date of the Action:

23/10/2026

CSO approval date:

27/05/2022

Memorandum of Understanding (MoU)

Download file

Contact Points
Chair:

Maria Paola Costi

Vice-Chair:

Anabela Cordeiro da Silva

COST staff

Scientific Officer:
Wioleta Walentowska
Administrative Officer:
Nathalie Warenghien

Administrative Team

Maria Cristina Notarsanto
Maria Esposito and Laura Leonardi